FDAHealthApril 24, 2026
Lupin Pharmaceuticals Inc. — Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA
⚠️ Presence of particulate matter: a white thread-like structure in the cartridge
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- April 24, 2026
Nationwide within U.S
What's affected?
- Product
- Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
- Brand
- LIRAGLUTIDE
- Lot code
- a)
Additional details
Lots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027; WB00103, Expires: Oct. 2027; WC00016, Expires: Dec. 2027; b) WB00098, WB00092, WB00093, Expires: Jul. 2027; WB00104, WB00106, WB00105, Expires: Oct. 2027.
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 217,621 pen injectors.
Get Health recall alerts
Delivered to your inbox. Free. No account required.